SONA Sona Nanotech Inc.

CNQ · CA · Healthcare · Biotechnology · sonanano.com

0.3300CAD0.00%Mkt Cap: 27.49M $P/E: —3d ago

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

$23.37BUSDP/E 14.7

GMAB

Genmab A/S - American Depositary Shares

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap27.49M USD

Enterprise Value29.75M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-2.37M USD

Revenue/Share—

Last Price0.3300 CAD

Fiscal Year EndOct 2025

MR QuarterJul 2026

Employees—

CountryCA

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-22.59

EV/Revenue—

P/S—

P/B-55.00

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.260012% of range0.8400

52W High0.8400 CAD

52W Low0.2600 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE8381.93%

ROA-244.46%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.43M USD

CapEx (TTM)—

FCF Margin—

FCF Yield0.11%

Net Debt235.19K USD

Net Debt/EBITDA-0.18

Balance Sheet

Debt/Equity-7.94

Current Ratio0.04

Quick Ratio0.01

Book Value/Sh-0.0060 CAD

Cash/Share0.00 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.122.80M

Float104.75M

Insiders17.63%

Institutions0.00%

Short Interest

Short Ratio0.6d

Short % Out.0.02%

Shares Short26.59K

Short (prev mo.)4.00K

Technical

SMA 500.3412 (-3.3%)

SMA 2000.3531 (-6.5%)

Beta1.03

S&P 52W Chg14.58%

Avg Vol (30d)41.34K

Avg Vol (10d)24.29K

Technical Indicators

RSI (14)51.7

MACD0.0065

MACD Signal0.0080

MACD Hist.-0.0015

BB Upper0.3728 CAD

BB Middle0.3240 CAD

BB Lower0.2752 CAD

BB Width30.15%

ATR (14)0.0282 CAD

Vol Ratio (20d)0.05x